Which Women Choose Hormones for Surgical Menopause? Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
Survival Effect of pCR Elusive in Breast Cancer 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Jul 23, 2020
Older Age Should Not Rule Out Chemo in Breast Cancer Patients Providers should consider patient priorities when discussing treatment Jul 17, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Brief Quasi-Fasting Diet Boosts Breast Cancer Chemo Response Randomized trial in neoadjuvant setting Jun 28, 2020
Pembrolizumab May Help in Triple-Negative Breast Cancer Upfront therapy extends progression-free survival in metastatic disease, study shows Jun 01, 2020
Surgery for Metastatic Breast Cancer Fails to Boost Overall Survival Cumulative data, though, don't rule out benefit for selected patients with de novo stage IV disease Jun 01, 2020
Add-On Tucatinib Ups Survival in Breast Cancer With Brain Mets TKI plus trastuzumab-capecitabine reduced risk of death by nearly half Jun 01, 2020
HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
New Clue to Anti-PD-L1 Activity in Breast Cancer? Survival benefit with durvalumab in patients with PDL1 copy number alteration May 26, 2020
Five Days of G-CSF Adequate for Breast Cancer Chemo Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
Honing Chemo Use in Small Breast Tumors Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
Talzenna Misses OS Endpoint in BRCA-Positive Breast Cancer But PARP inhibitor improved patient-reported outcomes over standard therapy Apr 29, 2020
Anti-PD-L1 Plus PARP Inhibitor Ups Response in Breast Cancer Add-on treatment superior to chemo alone, but questions remain about cost, toxicity Apr 28, 2020
Hormone Levels Tied to Future Breast Cancer Risk "New avenues for exploration" in risk stratification Apr 24, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
Beyond CDK4/6 Inhibitors for HR-Positive Breast Cancer Switching drugs, taking aim at different targets under investigation Mar 11, 2020
Shannen Doherty's Stage IV Breast Cancer "Beverly Hills, 90210" star says she's "petrified" Feb 20, 2020
Bell Ringing Not So Joyous for Cancer Patients? Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
Bad News on Anti-HER2 Heart Effects Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
Oral Paclitaxel Bests IV Delivery in Advanced Breast Cancer But high pill count, lengthy dosing schedule could prove to be problematic Dec 14, 2019
Residual Breast Cancer Tool Highly Prognostic After Neoadjuvant Tx Tumor burden calculator predicted long-term outcomes in all breast cancer subtypes Dec 14, 2019
Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
HRT Has 20-Year Impact on Breast Cancer Risks Prospective data confirm long-term benefit with estrogen-only and harm with added progestin Dec 13, 2019
Checkpoints Show Different Outcomes in Breast Cancer Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancer Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
Edging Closer to OS Benefit With Novel Anti-HER2 Drug Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
New Standard for Metastatic HER2 Breast Cancer Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
Study Suggests Viable Alternative to Mastectomy After In-Breast Recurrence Mastectomy rates low, good cancer control in selected patients Nov 21, 2019
Sex Assault at Mt. Sinai; Pharma's MD Millionaires; Mammography Marketing Machine This past week in healthcare investigations Oct 23, 2019
Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
Wires or RFID Tags in Breast Cancer Excision? Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
The Legacy of Henry Lynch, MD Earlier this summer the legendary researcher passed, his contributions to cancer research are immeasurable Sep 01, 2019
Olivia Newton-John's Stage 4 Cancer Cannabis Management The singer and actress updates fans on her battle, but can marijuana help? Aug 22, 2019
